Economic evaluations the role of the US government, not the FDA? Comment 30 January 2013 Pages: 2 - 2
Desloratadine a QOL tonic for chronic idiopathic urticaria, SAR Meeting report 30 January 2013 Pages: 3 - 4
Lipid-lowering therapy use below par among Danish IHD patients Clinical study 30 January 2013 Pages: 5 - 5
One-dose immunisation best for meningococcal group C infections Clinical study 30 January 2013 Pages: 5 - 5
Greater adherence to hypertension guidelines could save > $US1 billion Clinical study 30 January 2013 Pages: 6 - 6
Which methodology for estimating breast cancer expenditures? Clinical study 30 January 2013 Pages: 6 - 6
Amphotericin B lipid complex best value lipid therapy in mycoses Clinical study 30 January 2013 Pages: 7 - 7
Infant vaccination intervention only marginally successful Clinical study 30 January 2013 Pages: 7 - 7
Venlafaxine worthwhile for first-line depression treatment in the UK Clinical study 30 January 2013 Pages: 7 - 7
Galactosaemia: costs of newborn screening outweigh benefits Clinical study 30 January 2013 Pages: 8 - 8
Potential savings huge from greater use of generics among US elderly Clinical study 30 January 2013 Pages: 8 - 8
Productivity losses account for large burden of epilepsy in India Clinical study 30 January 2013 Pages: 8 - 8
Inhaled corticosteroids worth it in patients with severe COPD Clinical study 30 January 2013 Pages: 9 - 9
Intervention somewhat effective in hypertension, hyperlipidaemia Clinical study 30 January 2013 Pages: 9 - 9
Newer antipsychotics prescribed often for off-label indications in Italy Clinical study 30 January 2013 Pages: 9 - 9
Sildenafil safely improves QOL in men with moderate heart failure? Clinical study 30 January 2013 Pages: 10 - 10
Artesunate/amodiaquine to replace chloroquine as first-line malaria treatment in Ghana News item 30 January 2013 Pages: 11 - 11